Bad Offer, Good Business: Why Strong Healthcare Companies Still Get Undervalued
Bad Offer, Good Business: Why Strong Healthcare Companies Still Get Undervalued Key Takeaways A Good Business Can Still Attract a Bad Offer A strong healthcare company does not automatically receive a strong valuation. In today’s market, buyers are active but far more selective. Even well-performing businesses can receive conservative offers when uncertainty appears. Strong fundamentals […]
Read More
How to Present Healthcare Company Culture and Team Stability as a Real Asset
How to Present Healthcare Company Culture and Team Stability as a Real Asset Key Takeaways Why Buyers Care About Culture Healthcare buyers are not only buying EBITDA. They are buying continuity, leadership trust, and the likelihood that performance will hold after closing. That is why cultural diligence matters in a sale process, especially when it […]
Read More
How to Package Healthcare Company Add-Backs the Right Way (Without Losing Trust)
How to Package Healthcare Company Add-Backs the Right Way (Without Losing Trust) Key Takeaways Why Add-Backs Become a Trust Issue In healthcare M&A, buyers do not automatically reject add-backs; they reject uncertainty. When adjustments feel vague, recurring, or poorly supported, trust drops fast. That is why sellers should prepare earnings support early, much like a […]
Read More
Why Data Infrastructure Is Replacing Growth as the Primary Value Signal
Why Data Infrastructure Is Replacing Growth as the Primary Value Signal Key Takeaways The Healthcare Valuation Shift Most Owners Don’t See Coming For years, healthcare owners were told a simple story: grow revenue, and the valuation will follow. That logic worked in an era of cheap capital, aggressive roll-ups, and limited diligence scrutiny. Today, that […]
Read More